Pharmacists' contributions to the management of opioid use disorder

Paul M. Stranges; Kathleen K. Adams; Anwar Alharir; Lindy G. Burnam; Abigail T. Elmes-Patel; Sage B. Greenlee; Alexander F. Infante; Angela Kerins; Qing Ma; Lyndsi K. Meyenburg; Cecilia Nyman; Golden L. Peters; Kerry Anne Rambaran; D. Max Smith; David E. Zimmerman

doi:10.1002/jac5.70049

Pharmacists' contributions to the management of opioid use disorder

Paul M. Stranges
, Kathleen K. Adams
, Anwar Alharir
, Lindy G. Burnam
, Abigail T. Elmes-Patel
, Sage B. Greenlee
, Alexander F. Infante
, Angela Kerins
, Qing Ma
, Lyndsi K. Meyenburg
, Cecilia Nyman
, Golden L. Peters
, Kerry Anne Rambaran
, D. Max Smith
, David E. Zimmerman

Pharmacy

American College of Clinical Pharmacy

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Clinicians continue to work toward ending the opioid-related overdose and death epidemic in the United States. Opioid use disorder (OUD) is a chronic and relapsing disease characterized by an overpowering desire to use opioids despite serious adverse effects, impairment, or distress. Management of OUD requires team-based care. Pharmacists are uniquely positioned to contribute to the management of OUD in all stages and have demonstrated positive outcomes. Pharmacists are the most accessible health care professionals in community settings, and they practice in all settings across the health care continuum. However, opportunities exist to bridge the disparity between the demand for treatment and its availability. Regulatory barriers limit innovation and expansion of pharmacy services. This white paper describes pharmacists' contributions to the management of OUD and identifies opportunities to leverage pharmacists within the health care landscape to improve patient outcomes.

Original language	English
Pages (from-to)	500-510
Number of pages	11
Journal	JACCP Journal of the American College of Clinical Pharmacy
Volume	8
Issue number	6
DOIs	https://doi.org/10.1002/jac5.70049
State	Published - Jun 2025

Keywords

medications to treat opioid use disorder (MOUD)
opioid use disorder
patient outcomes
pharmacists

Access to Document

10.1002/jac5.70049

Cite this

Stranges, P. M., Adams, K. K., Alharir, A., Burnam, L. G., Elmes-Patel, A. T., Greenlee, S. B., Infante, A. F., Kerins, A., Ma, Q., Meyenburg, L. K., Nyman, C., Peters, G. L., Rambaran, K. A., Smith, D. M., & Zimmerman, D. E. (2025). Pharmacists' contributions to the management of opioid use disorder. JACCP Journal of the American College of Clinical Pharmacy, 8(6), 500-510. https://doi.org/10.1002/jac5.70049

@article{c7c7888c9d6448d582a5d6c43af9de77,

title = "Pharmacists' contributions to the management of opioid use disorder",

abstract = "Clinicians continue to work toward ending the opioid-related overdose and death epidemic in the United States. Opioid use disorder (OUD) is a chronic and relapsing disease characterized by an overpowering desire to use opioids despite serious adverse effects, impairment, or distress. Management of OUD requires team-based care. Pharmacists are uniquely positioned to contribute to the management of OUD in all stages and have demonstrated positive outcomes. Pharmacists are the most accessible health care professionals in community settings, and they practice in all settings across the health care continuum. However, opportunities exist to bridge the disparity between the demand for treatment and its availability. Regulatory barriers limit innovation and expansion of pharmacy services. This white paper describes pharmacists' contributions to the management of OUD and identifies opportunities to leverage pharmacists within the health care landscape to improve patient outcomes.",

keywords = "medications to treat opioid use disorder (MOUD), opioid use disorder, patient outcomes, pharmacists",

author = "Stranges, \{Paul M.\} and Adams, \{Kathleen K.\} and Anwar Alharir and Burnam, \{Lindy G.\} and Elmes-Patel, \{Abigail T.\} and Greenlee, \{Sage B.\} and Infante, \{Alexander F.\} and Angela Kerins and Qing Ma and Meyenburg, \{Lyndsi K.\} and Cecilia Nyman and Peters, \{Golden L.\} and Rambaran, \{Kerry Anne\} and Smith, \{D. Max\} and Zimmerman, \{David E.\}",

note = "Publisher Copyright: {\textcopyright} 2025 ACCP Foundation, Ltd.",

year = "2025",

month = jun,

doi = "10.1002/jac5.70049",

language = "English",

volume = "8",

pages = "500--510",

journal = "JACCP Journal of the American College of Clinical Pharmacy",

issn = "2574-9870",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "6",

}

Stranges, PM, Adams, KK, Alharir, A, Burnam, LG, Elmes-Patel, AT, Greenlee, SB, Infante, AF, Kerins, A, Ma, Q, Meyenburg, LK, Nyman, C, Peters, GL, Rambaran, KA, Smith, DM & Zimmerman, DE 2025, 'Pharmacists' contributions to the management of opioid use disorder', JACCP Journal of the American College of Clinical Pharmacy, vol. 8, no. 6, pp. 500-510. https://doi.org/10.1002/jac5.70049

TY - JOUR

T1 - Pharmacists' contributions to the management of opioid use disorder

AU - Stranges, Paul M.

AU - Adams, Kathleen K.

AU - Alharir, Anwar

AU - Burnam, Lindy G.

AU - Elmes-Patel, Abigail T.

AU - Greenlee, Sage B.

AU - Infante, Alexander F.

AU - Kerins, Angela

AU - Ma, Qing

AU - Meyenburg, Lyndsi K.

AU - Nyman, Cecilia

AU - Peters, Golden L.

AU - Rambaran, Kerry Anne

AU - Smith, D. Max

AU - Zimmerman, David E.

PY - 2025/6

Y1 - 2025/6

N2 - Clinicians continue to work toward ending the opioid-related overdose and death epidemic in the United States. Opioid use disorder (OUD) is a chronic and relapsing disease characterized by an overpowering desire to use opioids despite serious adverse effects, impairment, or distress. Management of OUD requires team-based care. Pharmacists are uniquely positioned to contribute to the management of OUD in all stages and have demonstrated positive outcomes. Pharmacists are the most accessible health care professionals in community settings, and they practice in all settings across the health care continuum. However, opportunities exist to bridge the disparity between the demand for treatment and its availability. Regulatory barriers limit innovation and expansion of pharmacy services. This white paper describes pharmacists' contributions to the management of OUD and identifies opportunities to leverage pharmacists within the health care landscape to improve patient outcomes.

AB - Clinicians continue to work toward ending the opioid-related overdose and death epidemic in the United States. Opioid use disorder (OUD) is a chronic and relapsing disease characterized by an overpowering desire to use opioids despite serious adverse effects, impairment, or distress. Management of OUD requires team-based care. Pharmacists are uniquely positioned to contribute to the management of OUD in all stages and have demonstrated positive outcomes. Pharmacists are the most accessible health care professionals in community settings, and they practice in all settings across the health care continuum. However, opportunities exist to bridge the disparity between the demand for treatment and its availability. Regulatory barriers limit innovation and expansion of pharmacy services. This white paper describes pharmacists' contributions to the management of OUD and identifies opportunities to leverage pharmacists within the health care landscape to improve patient outcomes.

KW - medications to treat opioid use disorder (MOUD)

KW - opioid use disorder

KW - patient outcomes

KW - pharmacists

UR - https://www.scopus.com/pages/publications/105007522855

U2 - 10.1002/jac5.70049

DO - 10.1002/jac5.70049

M3 - Article

AN - SCOPUS:105007522855

SN - 2574-9870

VL - 8

SP - 500

EP - 510

JO - JACCP Journal of the American College of Clinical Pharmacy

JF - JACCP Journal of the American College of Clinical Pharmacy

IS - 6

ER -

Pharmacists' contributions to the management of opioid use disorder

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this